FIND FIND Project Aims to Accelerate Targeted NGS Solutions for Global Drug-Resistant TB Testing Premium The multi-year project led by FIND is currently evaluating three end-to-end solutions through clinical studies. FIND Invests $21M to Launch POC MDx Platforms for Infectious Disease Four companies have been selected for investment: Biomeme, Bioneer, Qlife, and SD Biosensor. Global Fund Awards FIND $37M for TB Dx in India The new funding from the Global Fund will support three projects that aim to improve early diagnosis of tuberculosis in India through 2024. Sequencing-Based Tuberculosis Drug Resistance Testing Gaining Momentum Premium The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured. Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test Premium The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays. Mar 27, 2020 UK Government Invests $28M in FIND to Support SARS-CoV-2 Test Development Mar 24, 2020 Q&A: FIND's Cassandra Kelly-Cirino Discusses COVID-19 Diagnostics Pipelines Feb 20, 2020 FIND, WHO Collaborate on Novel Coronavirus MDx Evaluation Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Jul 5, 2019 FIND, Unitaid Sign $14.5M Deal to Evaluate NGS-Based Diagnosis of Drug-Resistant TB Apr 30, 2019 Malaria Test from Eiken Chemical Detects Less-Diagnosed Species Premium Sep 19, 2018 India's MolBio Brings Tuberculosis MDx to Point of Care With Help From FIND Premium Aug 8, 2018 Genedrive, FIND Partner on HCV Assay Evaluation Study Aug 30, 2017 Study Highlights Cepheid's Next-Generation TB, Rifampicin Resistance Assay Premium Dec 3, 2015 Cepheid, FIND to Evaluate Point-of-Care MDx System, TB Test Oct 8, 2015 Consortium Seeks to Provide Centralized Access to Global TB Data for Research, Dx Development Premium Oct 7, 2015 Paul G. Allen Ebola Program Awards $6.9M for Ebola Diagnostics Jul 1, 2015 Field Evaluation of Rapid Ebola Immunoassay Reveals Limitations of PCR-Based Testing Premium Apr 16, 2015 Cepheid Qualitative HIV-1 Test Receives CE Mark Mar 19, 2015 Study IDs TB Strains in Swaziland with Drug Resistance Mutations Not Detected by Cepheid Xpert Test Premium Dec 29, 2014 Cepheid's HIV MDx Assay Gains CE-IVD Mark Oct 28, 2014 FIND Collaborates with Multiple Firms on MDx Tests for TB May 23, 2013 Studies Indicate Effectiveness of New LAMP-based Malaria Test in Modern Labs, Endemic Countries Premium Apr 18, 2013 Lumora-FIND Malaria Screening Test May be Tip of Iceberg in MDx Development Partnership Premium Apr 17, 2013 Lumora, FIND Partner to Develop High-throughput Malaria Assay Load More Breaking News Mitochondrial Protein Resource Reveals New Disease Players StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test OraSure Technologies Selected by HHS to Provide COVID-19 School Testing Hologic Obtains CE Mark for Molecular Epstein-Barr, BK Virus Assays Multiomics Startup Pleno Closes $15M Funding Round SeekIn Gets CE Mark for Cancer Treatment Response Monitoring Kit The Scan UK Moves to Allow Sale of Gene-Edited Food The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist. Questions for the Field Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do. Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more. Taking Stock of the Stockpile The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.